Steward Partners Investment Advisory
MXCT icon

Steward Partners Investment Advisory’s MaxCyte MXCT Stock Holding History

Steward Partners Investment Advisory’s Portfolio MXCT Stock Details MXCT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-168
Closed -$118 – 4796
2026
Q1 		$118 Hold
168
– – ﹤0.01% 4341
2025
Q4 		$260 Hold
168
– – ﹤0.01% 4186
2025
Q3 		$265 Buy
+168
New +$292 ﹤0.01% 4163
2024
Q2 		– Sell
-1,630
Closed -$6.83K – 3678
2024
Q1 		$6.83K Hold
1,630
– – ﹤0.01% 2947
2023
Q4 		$7.66K Hold
1,630
– – ﹤0.01% 2809
2023
Q3 		$5.09K Buy
+1,630
New +$6.55K ﹤0.01% 2819

Other funds holding MXCT

CFM
Capricorn Fund Managers London, United Kingdom $1.27B AUM 70.17% 1-Year Est. Return
VP
Vitruvian Partners London, United Kingdom $201M AUM 10.44% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
MA
Mudita Advisors London, United Kingdom $481M AUM 73.74% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
BFM
Brooklands Fund Management London, United Kingdom $128M AUM
BNP Paribas Asset Management
BNP Paribas Asset Management Paris, France $99.8B AUM 45.22% 1-Year Est. Return
CCM
Cadian Capital Management New York $1.32B AUM 4.19% 1-Year Est. Return
PLC
Peapod Lane Capital Bedford Hills, New York $148M AUM 89.92% 1-Year Est. Return

Steward Partners Investment Advisory's MXCT Position: Q2 2026 in Review

Steward Partners Investment Advisory sold out of MaxCyte (MXCT) in Q2 2026, closing a stake of 168 shares — an estimated $118 sold.

Steward Partners Investment Advisory first reported a position in MXCT in Q3 2023 and held it in 6 quarters. The position peaked at $7.66K in Q4 2023. 122 funds tracked by Wall St. Rank hold MXCT as of Q2 2026.

  • Steward Partners Investment Advisory reported no remaining MaxCyte position as of Q2 2026 after selling out during the quarter.
  • Steward Partners Investment Advisory sold 168 MaxCyte shares in Q2 2026, an estimated $118.
  • Steward Partners Investment Advisory first reported a position in MaxCyte in Q3 2023 and held it in 6 quarters.
  • Steward Partners Investment Advisory's MaxCyte position peaked at $7.66K in Q4 2023.
  • 122 funds tracked by Wall St. Rank held MaxCyte as of Q2 2026.

Based on Steward Partners Investment Advisory's 13F filing for Q2 2026, filed 13 Aug 2026.